scorecardresearch
Business Today
Subscribe
Immersives UPSTART G20 Summit Corporate Petrol-Diesel Weather BT Bazaar
BT 100 BT Accenture PwC De-risking the Future BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
News
Markets
Stocks
Bliss GVS Pharma Ltd

Feedback
Bliss GVS Pharma Ltd

Bliss GVS Pharma Ltd (BLISSGVS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 175,134
Sep 14, 2023 15:56 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹94.70
₹0.80 (0.85%)
₹93.1 Low
Today’s Performance
₹95.2 High
₹69.2 Low
52 Week’s Performance
₹104 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 0.85%
  • 1 Week -3.47%
  • 1 Month 2.71%
  • 3 Months 18.60%
  • 6 Months 25.68%
  • 1 Year 11.22%
  • 3 Years -14.94%
  • 5 Years -12.41%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta 0.61
  • 52-Week Low (₹) 69.20
  • 52-Week High (₹) 104.00
  • Price-to-Book (X)* 1.12
  • Dividend Yield (%) 0.53
  • Price-to-Earnings (P/E) (X)* 16.50
  • Earnings Per Share (₹) 5.73
  • Sector Price Earning (X)* 33.20
  • Market Cap (₹ Cr.)* 988.66
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 39:53 Historic India-Middle East-Europe Corridor Puts China On Notice
THUMB 5:05 Delhi Tops In Terms Of Electric Buses After Arvind Kejriwal Govt Introduces 400 New Buses
thumb 4:42 The India-Middle East-Europe Corridor: A Counter To China's Belt & Road Initiative
THUMB 4:04 Putin Praises Modi’s ‘Make In India’, Cites Example To Russian Auto Industry
THUMB 9:44 Tata Motors' Electrifying Future: In Conversation With Shailesh Chandra On EV Expansion
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Aug 18, 2023 PURCHASE
BLISSGVS ,JAINAM SHARE CONSULTANTS PVT. LTD.
  • Qty 1089161
  • Average Price ₹91.55
Aug 18, 2023 Sell
BLISSGVS ,M/S. PRARTHANA ENTERPRISES
  • Qty 1089161
  • Average Price ₹91.55
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

FAQ’S

What was Bliss GVS Pharma Ltd share price previously?
Bliss GVS Pharma Ltd share price was up by 0.85% from the previous closing price of ₹93.90.
Who are peers of Bliss GVS Pharma Ltd?
The peers of Bliss GVS Pharma Ltd are Biocon Ltd, Alkem Laboratories Ltd, Dr Reddys Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Cipla Ltd, Lupin Ltd, Syngene International Ltd, Glaxosmithkline Pharmaceuticals Ltd, Gland Pharma Ltd, Aurobindo Pharma Ltd, Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Bliss GVS Pharma Ltd?
The promotor/promotors of Bliss GVS Pharma Ltd are Vibha G Sharma, Shruti Vishal Rao, Subramanian R Vaidya, Santosh Parab, Aditi Bhatt, Shilpa Bhatia, Gagan Harsh Sharmma.
What has been 52-week high of Bliss GVS Pharma Ltd stocks?
The highest price of Bliss GVS Pharma Ltd stock is ₹104.00 in the last 52-week.
What is the share price of Bliss GVS Pharma Ltd (BLISSGVS) today on NSE?
As on Sep 14, 2023, Bliss GVS Pharma Ltd (BLISSGVS)’s share price on NSE is Rs 94.7
What is the market cap of Bliss GVS Pharma Ltd (BLISSGVS?)
The current market capitalisation of Bliss GVS Pharma Ltd (BLISSGVS) is 988.66 crores
What is Bliss GVS Pharma Ltd Share symbol?
The symbol of Bliss GVS Pharma Ltd is BLISSGVS.
What is the PE ratio of Bliss GVS Pharma Ltd (BLISSGVS)?
The current PE ratio of Bliss GVS Pharma Ltd (BLISSGVS) is 16.50.
What is the PB ratio of Bliss GVS Pharma Ltd (BLISSGVS)?
The current PB ratio of Bliss GVS Pharma Ltd (BLISSGVS) is 1.12.
Today’s High & Low share prices of Bliss GVS Pharma Ltd (BLISSGVS) on NSE?
Today, the share price of Bliss GVS Pharma Ltd (BLISSGVS) on NSE touched a high of Rs 95.2 and a low of Rs 93.1
What price did Bliss GVS Pharma Ltd (BLISSGVS) shares open on the NSE today?
On NSE, the share price of Bliss GVS Pharma Ltd (BLISSGVS) opened at Rs 94.05
What is the 52-week high of Bliss GVS Pharma Ltd (BLISSGVS)?
The 52-week high price of Bliss GVS Pharma Ltd (BLISSGVS) is Rs 104
What is the 52-week low of Bliss GVS Pharma Ltd (BLISSGVS) ?
The 52-week low price of Bliss GVS Pharma Ltd (BLISSGVS) is Rs 69.2

ABOUT BLISS GVS PHARMA

Bliss GVS Pharma Ltd, incorporated in the year 1984, has its registered office in 102 Hyde Park Sakivihar Road, Andheri East, Mumbai, Maharashtra, 400072, 91-22-42160000, 91-22-28563930. The main industry in which Bliss GVS Pharma Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Bliss GVS Pharma Ltd is/are Kalyaniwalla & Mistry LLP. In the main management, Subramanian R Vaidya is chairman and Aditi Bhatt is the company secretary for Bliss GVS Pharma Ltd.

  • VGS Vibha G Sharma Whole-time Director
  • SVR Shruti Vishal Rao Whole-time Director
  • SRV Subramanian R Vaidya Chairman & Independent Directo
  • SP Santosh Parab Non-Exec. & Independent Dir.
  • AB Aditi Bhatt Company Sec. & Compli. Officer
  • SB Shilpa Bhatia Non-Exec. & Independent Dir.
  • GHS Gagan Harsh Sharmma Managing Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.